Fig. 2: Outcome according to disease origin (de novo vs secondary or treatment-related AML) for patients in the outcome set (n = 534).
a Cumulative incidence of relapse, b non-relapse mortality, and c overall survival in all patients.
Fig. 2: Outcome according to disease origin (de novo vs secondary or treatment-related AML) for patients in the outcome set (n = 534). | Bone Marrow Transplantation
